Dr. Ainat Beniaminovitz, MD

Dr. Beniaminovitz practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Beniaminovitz's NPI, 1780603860, was assigned on July 19, 2006. Dr. Beniaminovitz graduated from Vagelos College of Physicians and Surgeons in 1990. Dr. Beniaminovitz holds New York license 190450.

Dr. Beniaminovitz's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Beniaminovitz's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Beniaminovitz is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Beniaminovitz to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beniaminovitz practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Beniaminovitz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Beniaminovitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Beniaminovitz's licenses on file in 3 states: New York, California and Florida.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Beniaminovitz treats.

CMS data shows 7,158 Medicare services from Dr. Beniaminovitz across 20 procedure codes in 2024, for 1,970 Medicare patients. Medicare paid $660,024 for them. Every service was in an office.

CMS counts 1,970 Medicare patients who saw Dr. Beniaminovitz in 2024. The largest group is 75 to 84, with 926 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beniaminovitz's median patient age at 67, with 62% women.

In 2024, Dr. Beniaminovitz wrote 17,393 Medicare Part D claims for 2,121 patients. 87% of them were for generic drugs. CMS names the drug for 16,879 of them, across 105 drugs with 11 or more claims each, at $3,581,825 in total drug cost. In 2023, CMS named 15,082 claims across 99 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Beniaminovitz for performance year 2024, reported through an alternative payment model (APM). Dr. Beniaminovitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beniaminovitz as offering telehealth.

Dmand AI links 18 papers to Dr. Beniaminovitz in 2018. The most frequent topics are Heart Transplantation, Exercise Test and Heart Failure. Dr. Beniaminovitz has published most often in J Heart Lung Transplant. Dr. Beniaminovitz's most frequent co-authors are Niloo M. Edwards, MD, Katherine Lietz, MD, PhD and Mark E. Galantowicz, MD.

CMS Open Payments shows 22 general payments to Dr. Beniaminovitz from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbott Laboratories paid the most, $360.

Dmand AI lists 3 awards for Dr. Beniaminovitz, most recently Top Doctors: New York Metro Area in 2014.

Dr. Beniaminovitz graduated from Vagelos College of Physicians and Surgeons in 1990. Dr. Beniaminovitz is a member of ACC.

Dr. Beniaminovitz is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.